Keppra, manufactured by UCB Pharma is a drug indicated for those suffering from epilepsy. The actual drug in Keppra is called levetiracetam and part of the racetam family of drugs which includes the likes of piracetam, oxiracetam, aniracetam to name just a few. While the exact mechanism of action on how Keppra exerts is effects is not clear, we do know that it binds to a synaptic vesicle glycoprotein and inhibits calcium channels which helps reduce neurotransmitter release. With rapid delivery, Keppra is absorbed at close to 100 percent bioavailability.
Off-Label Use - In common with other racetam class drugs, Keppra has been used by those seeking to take advantage of its ability to potentially enhance cognitive functions with a view to enhancing users' ability to preserve memory, memory recall, and boost productivity. In addition, Keppra has also been used in managing various other conditions such as Tourette's, Alzeimer's disease and anxiety disorder.
Available since 2008 as, Keppra does not possess significant pharmokinetic interactions with other commonly prescribed drugs for those suffering from neurological diseases which makes it an effective choice for those on a multi-drug treatment regimen.
Keppra is licensed for epileptics and is prescribed in both sexes and in adults and children. Indeed, even infants from the age of 1 month old are sometimes given this medicine.
Keppra is usually dosed twice a day, once in the morning and again in the evening at approximately the same time each day. Dosing of Keppra can vary though with general adult doses of 1000mg to 3000mg a day. As with any medication, you should always take Keppra exactly as instructed by your doctor or pharmacist.